Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | IONS |
---|---|---|
09:32 ET | 52045 | 40.32 |
09:34 ET | 1300 | 40.6199 |
09:38 ET | 1986 | 40.53 |
09:39 ET | 1200 | 40.6314 |
09:41 ET | 2048 | 40.8 |
09:43 ET | 1000 | 40.8 |
09:45 ET | 3000 | 40.815 |
09:48 ET | 1900 | 40.81 |
09:50 ET | 722 | 40.87 |
09:52 ET | 2309 | 40.72 |
09:54 ET | 900 | 40.735 |
09:56 ET | 15052 | 40.58 |
09:57 ET | 4280 | 40.41 |
09:59 ET | 1700 | 40.36 |
10:01 ET | 13673 | 40.34 |
10:03 ET | 1450 | 40.32 |
10:06 ET | 2366 | 40.225 |
10:08 ET | 950 | 40.32 |
10:10 ET | 719 | 40.33 |
10:12 ET | 800 | 40.3 |
10:14 ET | 10345 | 40.2 |
10:15 ET | 5546 | 40.32 |
10:17 ET | 319 | 40.34 |
10:19 ET | 5002 | 40.2 |
10:21 ET | 1450 | 40.14 |
10:24 ET | 2099 | 40.24 |
10:26 ET | 300 | 40.27 |
10:28 ET | 2461 | 40.26 |
10:30 ET | 743 | 40.27 |
10:32 ET | 1800 | 40.27 |
10:33 ET | 1649 | 40.31 |
10:35 ET | 2200 | 40.32 |
10:37 ET | 1925 | 40.32 |
10:39 ET | 400 | 40.315 |
10:42 ET | 1963 | 40.27 |
10:44 ET | 879 | 40.24 |
10:46 ET | 1815 | 40.24 |
10:48 ET | 300 | 40.26 |
10:50 ET | 1789 | 40.18 |
10:51 ET | 900 | 40.165 |
10:53 ET | 3851 | 40.21 |
10:55 ET | 700 | 40.21 |
10:57 ET | 7582 | 40.13 |
11:00 ET | 4603 | 40.25 |
11:02 ET | 5802 | 40.22 |
11:04 ET | 2543 | 40.135 |
11:06 ET | 8568 | 40.03 |
11:08 ET | 11612 | 40.19 |
11:09 ET | 7924 | 40.1 |
11:11 ET | 3493 | 40.065 |
11:13 ET | 3681 | 40.075 |
11:15 ET | 3498 | 40.09 |
11:18 ET | 2400 | 40.11 |
11:20 ET | 2180 | 40.06 |
11:22 ET | 400 | 40.12 |
11:24 ET | 1200 | 40.115 |
11:26 ET | 700 | 40.11 |
11:27 ET | 1000 | 40.03 |
11:29 ET | 3117 | 40.02 |
11:31 ET | 1200 | 40.03 |
11:33 ET | 5137 | 39.98 |
11:36 ET | 9668 | 39.97 |
11:38 ET | 2345 | 39.96 |
11:40 ET | 7725 | 39.9298 |
11:42 ET | 15756 | 39.78 |
11:44 ET | 4578 | 39.78 |
11:45 ET | 6372 | 39.79 |
11:47 ET | 1300 | 39.7101 |
11:49 ET | 2489 | 39.75 |
11:51 ET | 5210 | 39.8 |
11:54 ET | 1500 | 39.8 |
11:56 ET | 1100 | 39.81 |
12:00 ET | 200 | 39.84 |
12:02 ET | 1392 | 39.795 |
12:03 ET | 1320 | 39.795 |
12:05 ET | 1940 | 39.81 |
12:07 ET | 1700 | 39.81 |
12:09 ET | 3165 | 39.77 |
12:12 ET | 1600 | 39.8 |
12:14 ET | 1100 | 39.785 |
12:16 ET | 1300 | 39.85 |
12:18 ET | 2600 | 39.845 |
12:20 ET | 2695 | 39.79 |
12:21 ET | 900 | 39.83 |
12:23 ET | 600 | 39.79 |
12:25 ET | 5629 | 39.87 |
12:27 ET | 6050 | 39.84 |
12:30 ET | 1110 | 39.85 |
12:32 ET | 1150 | 39.86 |
12:34 ET | 1538 | 39.86 |
12:38 ET | 1888 | 39.855 |
12:39 ET | 7124 | 39.895 |
12:41 ET | 4478 | 39.81 |
12:43 ET | 1250 | 39.88 |
12:45 ET | 2000 | 39.92 |
12:48 ET | 950 | 39.9 |
12:50 ET | 950 | 39.905 |
12:52 ET | 963 | 39.91 |
12:54 ET | 400 | 39.89 |
12:56 ET | 1332 | 39.86 |
12:57 ET | 12921 | 39.8 |
12:59 ET | 2052 | 39.84 |
01:01 ET | 3024 | 39.82 |
01:03 ET | 14331 | 39.92 |
01:06 ET | 21100 | 39.92 |
01:08 ET | 2225 | 39.92 |
01:10 ET | 2000 | 39.9375 |
01:12 ET | 866 | 39.95 |
01:14 ET | 3825 | 39.8204 |
01:15 ET | 16283 | 39.79 |
01:17 ET | 1377 | 39.81 |
01:19 ET | 1100 | 39.81 |
01:21 ET | 1777 | 39.86 |
01:24 ET | 10957 | 39.93 |
01:26 ET | 4366 | 39.8478 |
01:28 ET | 7569 | 39.885 |
01:30 ET | 700 | 39.865 |
01:32 ET | 8103 | 39.78 |
01:33 ET | 2186 | 39.83 |
01:35 ET | 2265 | 39.81 |
01:37 ET | 100 | 39.785 |
01:39 ET | 3299 | 39.8 |
01:42 ET | 1406 | 39.8 |
01:44 ET | 563 | 39.77 |
01:46 ET | 3941 | 39.79 |
01:48 ET | 4526 | 39.745 |
01:50 ET | 2745 | 39.77 |
01:51 ET | 2606 | 39.78 |
01:53 ET | 1300 | 39.76 |
01:55 ET | 1000 | 39.79 |
01:57 ET | 3852 | 39.78 |
02:00 ET | 1539 | 39.83 |
02:02 ET | 100 | 39.81 |
02:04 ET | 2280 | 39.77 |
02:06 ET | 2615 | 39.77 |
02:08 ET | 3877 | 39.71 |
02:09 ET | 4533 | 39.725 |
02:11 ET | 1500 | 39.75 |
02:13 ET | 1400 | 39.7 |
02:15 ET | 4708 | 39.72 |
02:18 ET | 900 | 39.73 |
02:20 ET | 1457 | 39.775 |
02:22 ET | 4089 | 39.785 |
02:24 ET | 14931 | 39.81 |
02:26 ET | 2879 | 39.795 |
02:27 ET | 4585 | 39.855 |
02:29 ET | 2550 | 39.905 |
02:31 ET | 1000 | 39.905 |
02:33 ET | 2750 | 39.915 |
02:36 ET | 14304 | 39.805 |
02:38 ET | 400 | 39.82 |
02:40 ET | 3357 | 39.75 |
02:42 ET | 10986 | 39.8 |
02:44 ET | 3809 | 39.81 |
02:45 ET | 11643 | 39.8 |
02:47 ET | 11713 | 39.84 |
02:49 ET | 6203 | 39.9 |
02:51 ET | 5136 | 39.875 |
02:54 ET | 3735 | 39.76 |
02:56 ET | 1650 | 39.77 |
02:58 ET | 540 | 39.725 |
03:00 ET | 2581 | 39.74 |
03:02 ET | 6524 | 39.8 |
03:03 ET | 1443 | 39.81 |
03:05 ET | 3126 | 39.83 |
03:07 ET | 1586 | 39.84 |
03:09 ET | 6450 | 39.82 |
03:12 ET | 7604 | 39.73 |
03:14 ET | 8628 | 39.68 |
03:16 ET | 4814 | 39.755 |
03:18 ET | 4109 | 39.685 |
03:20 ET | 2390 | 39.7 |
03:21 ET | 6954 | 39.695 |
03:23 ET | 4417 | 39.68 |
03:25 ET | 4336 | 39.71 |
03:27 ET | 1151 | 39.71 |
03:30 ET | 8561 | 39.65 |
03:32 ET | 12213 | 39.62 |
03:34 ET | 7981 | 39.635 |
03:36 ET | 17744 | 39.61 |
03:38 ET | 4076 | 39.64 |
03:39 ET | 3726 | 39.63 |
03:41 ET | 7062 | 39.6 |
03:43 ET | 32448 | 39.515 |
03:45 ET | 6641 | 39.5785 |
03:48 ET | 4968 | 39.64 |
03:50 ET | 8032 | 39.66 |
03:52 ET | 5249 | 39.675 |
03:54 ET | 20076 | 39.695 |
03:56 ET | 21199 | 39.825 |
03:57 ET | 26306 | 40.03 |
03:59 ET | 495289 | 40.06 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Ionis Pharmaceuticals Inc | 6.6B | -15.8x | --- |
Halozyme Therapeutics Inc | 7.9B | 22.2x | --- |
Tempus AI Inc | 7.6B | -6.9x | --- |
Intra-Cellular Therapies Inc | 8.0B | -84.8x | --- |
Ultragenyx Pharmaceutical Inc | 5.4B | -7.6x | --- |
Ascendis Pharma A/S | 6.9B | -15.5x | --- |
Ionis Pharmaceuticals, Inc. is engaged in ribonucleic acid (RNA)-targeted therapeutics. The Company has five marketed medicines and a pipeline in neurology, cardiology, and other areas of high patient need. It has nine medicines in Phase III development and multiple additional medicines in early and mid-stage development. The Company’s products include SPINRAZA, QALSODY, WAINUA, TEGSEDI and WAYLIVRA. SPINRAZA is used for the treatment of patients with spinal muscular atrophy (SMA), a progressive, debilitating and often fatal genetic disease. QALSODY is an antisense medicine that is used for the treatment of adult patients with superoxide dismutase 1 amyotrophic lateral sclerosis (SOD1-ALS), a rare, neurodegenerative disorder that causes progressive loss of motor neurons leading to death. WAINUA is a self-administered subcutaneous LIgand-Conjugated Antisense (LICA) medicine used for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis (ATTRv-PN).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $6.6B |
---|---|
Revenue (TTM) | $813.5M |
Shares Outstanding | 157.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.39 |
EPS | $-2.53 |
Book Value | $2.68 |
P/E Ratio | -15.8x |
Price/Sales (TTM) | 8.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -44.61% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.